APA (7th ed.) Citation

M, C., S, A., JB, G., DB, N., AM, A., JM, B., . . . JR, G. (2025). Reply to the Editor - Impact of mavacamten on atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy. Heart rhythm, 22(8), e537. https://doi.org/10.1016/j.hrthm.2025.01.027

Chicago Style (17th ed.) Citation

M, Castrichini, et al. "Reply to the Editor - Impact of Mavacamten on Atrial Fibrillation in Patients with Obstructive Hypertrophic Cardiomyopathy." Heart Rhythm 22, no. 8 (2025): e537. https://doi.org/10.1016/j.hrthm.2025.01.027.

MLA (9th ed.) Citation

M, Castrichini, et al. "Reply to the Editor - Impact of Mavacamten on Atrial Fibrillation in Patients with Obstructive Hypertrophic Cardiomyopathy." Heart Rhythm, vol. 22, no. 8, 2025, p. e537, https://doi.org/10.1016/j.hrthm.2025.01.027.